A clinical trial showed evidence supporting the use of the investigational nasal spray in reducing symptom scores of social and performance anxiety. Examples of conventional anti-anxiety pharmacotherapy are serotonin reuptake inhibitors, monoamine oxidase inhibitors, benzodiazepines, and beta-blockers. These drugs may cause adverse effects, take many days to be effective, or they may not be completely effective in some patients. The novel drug works through a pheromone pathway in the central nervous system and can be used immediately preceding an anxiety-inducing situation. Researchers have commented that a further study is needed to evaluate the efficacy in a larger sample size with a longer time period. What are your thoughts about this new agent?

For additional information, please see the article in Medscape.
Click on the link for the study in the American Journal of Psychiatry.

Image courtesy of [David Castillo Dominici]/FreeDigitalPhotos.Net